Literature DB >> 16757644

Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma.

Laura Pirilä1, Karl-Ove Söderström, Marja Hietarinta, Jari Jalava, Ville Kytö, Auli Toivanen.   

Abstract

A 42-year-old woman developed a rapidly progressing fatal heart failure. At the autopsy extensive necrosis of the myocardium was seen, with an almost complete absence of inflammatory cells and the presence of bacterial structures identified as Staphylococcus lugdunensis by PCR. In addition, the cytomegalovirus genome was found to be located inside the cardiomyocytes.

Entities:  

Mesh：

Year:  2006        PMID： 16757644      PMCID： PMC1489446          DOI： 10.1128/JCM.00002-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Fatal myocardial necrosis.

Authors:  M M Gordon; R Madhok
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

2.  Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.

Authors:  Ville Kytö; Tytti Vuorinen; Pekka Saukko; Irmeli Lautenschlager; Eberhard Lignitz; Antti Saraste; Liisa-Maria Voipio-Pulkki
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

3.  Direct amplification of rRNA genes in diagnosis of bacterial infections.

Authors:  K Rantakokko-Jalava; S Nikkari; J Jalava; E Eerola; M Skurnik; O Meurman; O Ruuskanen; A Alanen; E Kotilainen; P Toivanen; P Kotilainen
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Myocarditis: the Dallas criteria.

Authors:  H T Aretz
Journal:  Hum Pathol       Date:  1987-06       Impact factor: 3.466

5.  Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.

Authors:  I Anguera; A Del Río; J M Miró; X Matínez-Lacasa; F Marco; J R Gumá; G Quaglio; X Claramonte; A Moreno; C A Mestres; E Mauri; M Azqueta; N Benito; C García-de la María; M Almela; M-J Jiménez-Expósito; O Sued; E De Lazzari; J M Gatell
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

6.  Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience.

Authors:  R Patel; K E Piper; M S Rouse; J R Uhl; F R Cockerill; J M Steckelberg
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers.

Authors:  B Wilbrink; I M van der Heijden; L M Schouls; J D van Embden; J M Hazes; F C Breedveld; P P Tak
Journal:  Arthritis Rheum       Date:  1998-03

8.  Cytomegalovirus associated inflammatory heart muscle disease.

Authors:  B Maisch; U Schönian; M Crombach; I Wendl; C Bethge; M Herzum; H H Klein
Journal:  Scand J Infect Dis Suppl       Date:  1993

9.  Apoptotic cardiomyocyte death in fatal myocarditis.

Authors:  Ville Kytö; Antti Saraste; Pekka Saukko; Véronique Henn; Kari Pulkki; Tytti Vuorinen; Liisa-Maria Voipio-Pulkki
Journal:  Am J Cardiol       Date:  2004-09-15       Impact factor: 2.778
  9 in total
  3 in total

Review 1.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Fulminant staphylococcus lugdunensis septicaemia following a pelvic varicella-zoster virus infection in an immune-deficient patient: a case report.

Authors:  M Woznowski; I Quack; E Bölke; M Peiper; C Matuschek; S G Gatermann; L C Rump; Gisela Schieren
Journal:  Eur J Med Res       Date:  2010-09-24       Impact factor: 2.175

3.  Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging.

Authors:  Elena L Paley
Journal:  J Alzheimers Dis Rep       Date:  2021-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.